UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
She owed $7K due to a water leak. Her utility saw the signs but didn’t tell her
Birmingham Water Works flagged Claire Ahalt’s account for unusually high water use, but she did not find out until asking a utility worker weeks later.
City OK’s $5 million to help keep Birmingham-Southern College open
BSC President Daniel Coleman said in a statement that next he’ll ask Jefferson County to meet the city’s commitment, focus on private donors and reengage with state leaders to work on getting more funding.
A year after the Moody landfill fire: “We need just as much help now”
Around Thanksgiving a year ago a landfill near Moody caught fire blanketing the surrounding area with smoke. The fire burned for months before the Environmental Protection Agency covered the landfill with dirt to extinguish the flames, but there have been flare ups since. To understand what things are like now, we heard from one nearby resident.
Why trees are an environmental and health Swiss army knife
Cool Green Trees plants trees in under-resourced communities in the Birmingham area to help mitigate climate change and advance environmental justice initiatives.
A pro jiu-jitsu league is bringing grapplers from across the globe to a small city in Alabama
For acclaimed grappler Brandon Mccaghren, Decatur, Alabama, was the perfect place to grow the Professional Grappling Federation from idea to reality.
The flu is soaring in the South and rising elsewhere
The Centers for Disease Control and Prevention posted new flu data on Friday, showing very high activity last week in Louisiana, and high activity in Alabama, Florida, Georgia, Mississippi, New Mexico and South Carolina.
